Infinity Pharmaceuticals Capital Expenditure Trend

Infinity Pharmaceuticals Inc -- USA Stock  

USD 2.51  0.08  3.29%

This module enables investors to look at Infinity Pharmaceuticals various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Cost of Revenue of 32.5 M, Gross Profit of 6 M or Interest Expense of 1.6 M, but also many exotic indicators such as Long Term Debt to Equity of 0.2339, PPandE Turnover of 5.4358 or Receivables Turnover of 1 K. This module is a perfect complement to use when analyzing Infinity Pharmaceuticals Valuation or Volatility. It can also complement various Infinity Pharmaceuticals Technical models. Please also check analysis of Infinity Pharmaceuticals Correlation with competitors.
Showing smoothed Capital Expenditure of Infinity Pharmaceuticals Inc with missing and latest data points interpolated. A component of Net Cash Flow from Investing representing the net cash inflow (outflow) associated with the acquisition & disposal of long-lived, physical & intangible assets that are used in the normal conduct of business to produce goods and services and are not intended for resale. Includes cash inflows/outflows to pay for construction of self-constructed assets & software.
Capital Expenditure  10 Years Trend  
Slightly volatile
 Capital Expenditure 

Infinity Pharmaceuticals Capital Expenditure Over Time

2016-12-31 (6,426,000) 
2017-12-31 (6,426,000) 
2018-12-31 (7,560,000) 

Other Fundumenentals


Regression Statistics

Arithmetic Mean (3,308,570)
Coefficient Of Variation (72.68)
Mean Deviation  2,092,880
Median (2,091,102)
Standard Deviation  2,404,748
Range  6,259,000
R Value (0.75)
R Squared  0.56
Significance  0.00313
Slope (463,318)

Currently Trending

Sold over 70 shares of
2 days ago ago
Traded for 37.94
Purchased over 40 shares of
2 days ago ago
Traded for 61.5945
Sold over 200 shares of
2 days ago ago
Traded for 11.15